Chemotherapy-Induced Peripheral Neuropathy (CIPN) causes nerve pain and loss of sensation, often leading to numbness, tingling, burning, or other symptoms in the hands and feet. CIPN frequently ...

Researchers found that neuromuscular training can reduce the occurrence of chemotherapy-induced peripheral neuropathy (CIPN) by 50 to 70 percent. CIPN, a side effect of chemotherapy, can cause chronic ...

In a recent study published in JAMA Internal Medicine, researchers examine the potential of neuromuscular training to prevent chemotherapy-induced peripheral neuropathy (CIPN). Study: Preventive ...

Many cancer patients with chemotherapy-induced peripheral neuropathy (CIPN) will develop a chronic form of the disorder, according to findings from a systematic review and meta-analysis. For more than ...

People undergoing chemotherapy can experience considerable side effects, including nausea and vomiting, hair loss, mood changes and other health issues. New research shows 4 in 10 people who have ...

Nerve conduction studies show how well the body’s electrical signals travel down your nerves. During a nerve conduction study test, providers apply small electrical shocks to your nerve and record how ...

Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet – is a common side effect of certain cancer treatments, including two drugs frequently used ...

WOBURN, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of results from a NIH-funded clinical trial of Quell titled "Wireless transcutaneous electric nerve ...

WOBURN, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell® technology has received Breakthrough Designation from the U.S. Food and Drug ...

Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for years after treatment ends. Now a wave of basic science and early clinical ...